海外の治験の状況「前立腺癌」での検索結果
5965件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer
- Small Cell Prostate Cancer;Neuroendocrine Prostate Cancer;Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers;Small Cell Prostate Cancer;Neuroendocrine Prostate Cancer;Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers;Small Cell Prostate Cancer;Neuroendocrine Prostate Cancer;Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers;Small Cell Prostate Cancer;Neuroendocrine Prostate Cancer;Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers
- United States
- 2013-02-22
Recruiting
- Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
- Prostate Cancer
- Australia, Italy, United States
- 2013-02-14
Not recruiting
- Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans
- Prostate Cancer
- Netherlands
- 2013-02-08
Not recruiting
- Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer
- Prostate Adenocarcinoma;Recurrent Prostate Carcinoma;Stage I Prostate Adenocarcinoma AJCC v7;Stage II Prostate Adenocarcinoma AJCC v7;Stage III Prostate Adenocarcinoma AJCC v7
- United States
- 2013-02-06
Recruiting
- Clinical significance of [-2]proPSA during active surveillance for localized prostate cancer
- prostate cancer
- Japan
- 2013-01-25
Not recruiting
- Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer
- Adenocarcinoma of the Prostate
- Switzerland
- 2013-01-23
Not recruiting
- Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer
- Prostate Cancer
- United States
- 2013-01-11
Authorised
- CANTATA: Chemotherapy comparison in relapsing Prostate Cancer that has spread
- Metastatic Castrate Refractory Prostate Cancer;Therapeutic area: Diseases [C] - Cancer [C04]
- United Kingdom
- 2012-11-26
Authorised
- PHASE I/IIa STUDY OF VACCINE THERAPY IN PATIENTS WITH PROSTATE CANCER
- Patients with advanced oligometastatic prostate cancer (PCa) without lung and/or liver metastases who are eligible to Complete Androgen Blockade therapy (GnRH-agonist combined with anti-androgen). MedDRA version: 14.1 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: LLT Classification code 10071119 Term: Hormone-dependent prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Norway
- 2012-09-18
Authorised
- Randomized phase III trial comparing Jevtana in combination with hormone therapy to hormone therapy alone in metastatic prostate cancer
- Patients diagnosed with metastatic or high risk(PSA>100 or N1) prostate cancer. br>MedDRA version: 14.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Sweden
- 2011-06-30
